Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I'M WOMAN: Tranexamic Acid for Prevention of Postpartum Haemorrhage
NCT05562609Phase 3Recruiting
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Apr 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in postpartum hemorrhage (PPH) (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Risk of Postpartum haemorrhage at 24 hours. Started Apr 2024; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT05562609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05562609.